Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.4400
0.00 (0.00%)
Jun 30, 2026, 12:43 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 33.35 million as of July 1, 2026. Its market cap has decreased by -23.83% in one year.
Market Cap
33.35M
Enterprise Value
31.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.44
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 33.35M, a decrease of -62.57%. That is a compound annual growth rate of -17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 33.35M | -19.27% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 52.87M |
| NurExone Biologic | 51.55M |
| MedMira | 49.12M |
| Microbix Biosystems | 40.64M |
| BriaCell Therapeutics | 37.84M |
| Medicenna Therapeutics | 37.38M |
| Quantum BioPharma | 34.30M |
| Resverlogix | 30.95M |